SPDR Portfolio Intermediate Term Corporate Bond ETF (ARCA: SPIB)

Ultime notizie per SPDR Portfolio Intermediate Term Corporate Bond ETF (ARCA:SPIB)

SPDR Portfolio Intermediate Term Corporate Bond ETF

<h3>Gainers</h3>
<ul>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares moved upwards by 13.5% to $1.26 during Friday's after-market session. The company's market cap stands at $18.3 million. </li>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) shares moved upwards by 13.4% to $0.28. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares rose 11.94% to $2.25. The company's market cap stands at $6.1 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares moved upwards by 9.82% to $1.66. The company's market cap stands at $525.9 million. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock moved upwards by 6.99% to $0.65. The company's market cap stands at $32.8 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock increased by 5.87% to $0.82. The company's market cap stands at $10.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock decreased by 5.0% to $0.49 during Friday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) stock fell 4.29% to $1.34. The market value of their outstanding shares is at $19.7 million. </li>
<li>Rocky Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) shares declined by 4.26% to $21.4. The company's market cap stands at $163.6 million. </li>
<li>Live Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) shares fell 4.16% to $17.51. The market value of their outstanding shares is at $48.3 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares fell 3.82% to $6.55. The market value of their outstanding shares is at $3.6 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) stock fell 3.16% to $0.27. The market value of their outstanding shares is at $8.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ECDA

FTEL

GDHG

LIVE

NAAS

NDLS

NVFY

NWTN

PMNT

RCKY

VLCN

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock increased by 45.1% to $3.12 during Friday's after-market session. The market value of their outstanding shares is at $4.0 million. </li>
<li>Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) stock moved upwards by 20.0% to $1.5. The company's market cap stands at $79.8 million. </li>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) stock increased by 8.61% to $0.91. The market value of their outstanding shares is at $89.4 million. </li>
<li>Ovid Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) shares increased by 8.01% to $0.33. The company's market cap stands at $24.3 million. </li>
<li>RenovoRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>) stock moved upwards by 7.81% to $1.38. The market value of their outstanding shares is at $49.3 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares increased by 7.8% to $6.35. The company's market cap stands at $35.0 million. As per the press release, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock declined by 25.2% to $3.06 during Friday's after-market session. The company's market cap stands at $74.5 million. </li>
<li>Odysight ai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODYS#NASDAQ">ODYS</a>) shares decreased by 18.55% to $5.71. The market value of their outstanding shares is at $81.0 million. </li>
<li>Inhibikase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) shares declined by 16.05% to $1.36. The company's market cap stands at $122.6 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock fell 15.43% to $1.7. The company's market cap stands at $3.4 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock decreased by 12.1% to $3.56. The market value of their outstanding shares is at $2.4 million. </li>
<li>Synaptogenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPX#NASDAQ">SNPX</a>) shares declined by 7.2% to $5.61. The company's market cap stands at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

ODYS

OGEN

OVID

PLRX

RNXT

SERA

SNPX

VERO

VNRX

XCUR

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock moved upwards by 6.8% to $1.1 during Friday's after-market session. The market value of their outstanding shares is at $85.1 million. </li>
<li>INLIF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INLF#NASDAQ">INLF</a>) shares increased by 6.19% to $1.2. The market value of their outstanding shares is at $17.8 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock moved upwards by 5.96% to $0.26. The company's market cap stands at $71.8 million. </li>
<li>FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) stock increased by 5.96% to $0.51. The company's market cap stands at $84.1 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock increased by 5.64% to $1.49. The market value of their outstanding shares is at $15.6 million. </li>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares increased by 5.56% to $0.14. The market value of their outstanding shares is at $2.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phoenix Asia Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHOE#NASDAQ">PHOE</a>) shares declined by 8.6% to $6.88 during Friday's after-market session. The company's market cap stands at $160.2 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) shares decreased by 5.11% to $2.6. The market value of their outstanding shares is at $17.4 million. </li>
<li>WF Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) stock decreased by 5.02% to $3.79. The market value of their outstanding shares is at $167.2 million. </li>
<li>Concorde Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) shares declined by 4.95% to $9.22. The market value of their outstanding shares is at $181.7 million. </li>
<li>Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) stock decreased by 4.91% to $30.02. The market value of their outstanding shares is at $701.4 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) shares decreased by 4.87% to $10.36. The market value of their outstanding shares is at $72.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BYRN

CIGL

HKPD

INLF

JVSA

LNZA

NOTE

PHOE

YGMZ

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Mobilicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOB#NASDAQ">MOB</a>) stock moved upwards by 9.3% to $2.71 during Friday's after-market session. The company's market cap stands at $21.2 million. </li>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) shares increased by 7.97% to $1.07. The company's market cap stands at $10.9 million. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares rose 7.62% to $0.42. The company's market cap stands at $8.7 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 6.09% to $0.95. The market value of their outstanding shares is at $18.4 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) stock increased by 5.63% to $1.5. The market value of their outstanding shares is at $46.9 million. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock rose 5.09% to $0.33. The company's market cap stands at $17.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock decreased by 9.4% to $2.88 during Friday's after-market session. The market value of their outstanding shares is at $1.0 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 7.13% to $0.32. The market value of their outstanding shares is at $59.0 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock declined by 6.67% to $4.2. The company's market cap stands at $124.8 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock declined by 5.15% to $5.35. The company's market cap stands at $9.0 million. </li>
<li>Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) shares declined by 4.35% to $4.4. The company's market cap stands at $134.4 million. </li>
<li>Rackspace Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) stock decreased by 4.25% to $1.24. The market value of their outstanding shares is at $301.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRE

CLRO

CMCM

LIDR

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

PCLA

SVRE

WETH

YAAS

12 Information Technology Stocks Moving In Friday's After-Market Session

Boqii Holding Limited ("Boqii" or the "Company") (NYSE American:&nbsp;BQ) today announced that it will terminate the Deposit Agreement dated September 29, 2020 (the "Termination"), among the Company, The Bank of New York Mellon (the "Depositary"), and the owners and holders of American depositary shares (the "ADSs") from time to time in the near future, which was approved by its shareholders on June 26, 2025. In conjunction with this Termination, the Company will effect a reverse stock split, consolidating every 160 ordinary shares into one new ordinary share (the "Reverse Split").
In connection with the termination of the Company's ADR facility and Reverse Split, the Company plans to list its Class A ordinary shares for trading on NYSE American LLC ("AMEX") in substitution for the ADSs (the "Substitution Listing"). The Company expects that, upon the effectiveness of the Substitution Listing, its ADSs will cease to be listed on AMEX while the Class A ordinary shares represented by the ADSs will trade on AMEX under the symbol of "BQ." The Company has appointed VStock Transfer, LLC as its transfer agent in the United States for its ordinary shares. The new Committee on Uniform Securities Identification Procedures (CUSIP) for the Company's Class A ordinary shares number is G1311F119.

News

Stock Split

Boqii To Terminate ADR Program, Implement 160-For-1 Reverse Stock Split, And List Class A Ordinary Shares Directly On NYSE American

In the current session, the stock is trading at $106.00, after a 0.60% increase. Over the past month, State Street Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) stock increased by 10.10%, and in the past year, by 44.10%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751058019_0.png" alt="Past Year Chart" />

<h3>Comparing State Street P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 35.38 in the Capital Markets industry, State Street Inc. has a lower P/E ratio of 11.87. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751058019_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for State Street

EMCOR Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) has outperformed the market over the past 10 years by 15.76% on an annualized basis producing an average annual return of 27.24%. Currently, EMCOR Group has a market capitalization of $23.91 billion. 
Buying $1000 In EME: If an investor had bought $1000 of EME stock 10 years ago, it would be worth $11,011.00 today based on a price of $530.62 for EME at the time of writing.
<h3>EMCOR Group's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751058014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning EMCOR Group Stock In The Last 10 Years

<a href="https://www.globenewswire.com/Tracker?data=H9aHvFQXoefUFYRxjIHMf3bY-ZDzH-RfzLDA2A-u3_VBST2aGMuvffZuvJMDrqNRNs45puqoUZCD69Ui0QyDXA==">Gemini</a> today listed its first tokenized U.S. stock, MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), powered by Dinari, the leading provider of tokenized U.S. public securities. The launch opens trading to customers in Europe and Asia-Pacific and kicks off a series of public-equity offerings that pair Dinari's tokenization-on-demand infrastructure with Gemini's regulated platform.
Gemini has a history of debuting regulated, first-to-market products, from insured custody to the industry's earliest SOC-certified exchange. Adding tokenized U.S. equities is the next step in that roadmap, layering real-world stocks onto a venue that already supports more than 80 digital assets and safeguards roughly $8 billion in customer holdings.
Through Dinari's platform, Gemini users can now trade fully backed MicroStrategy (MSTR) dSharesTM alongside crypto. Dinari's rollout of 24/5 primary market trading to coincide with the launch offers customers traditional-market liquidity and transparent pricing, while Gemini's infrastructure offers seamless DeFi interoperability while maintaining a focus on compliance.
The rollout of the tokenized equity offering began for European and Asia-Pacific customers today and looks to extend to additional regions, including the United States, over the coming months.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

MSTR

Gemini Launches Tokenized MicroStrategy Stock Trading For Europe And Asia-Pacific Via Dinari, Expanding Regulated Access To U.S. Equities On Crypto Platform

- Reuters News
 https://www.reuters.com/sustainability/boards-policy-regulation/fed-says-banks-resilient-hypothetical-downturn-clearing-way-capital-plans-2025-06-27/#:~:text=WASHINGTON%2C%20June%2027%20(Reuters),Federal%20Reserve%20reported%20on%20Friday.

Macro Economic Events

Economics

Federal Reserve

'Federal Reserve Finds Large Banks Well-Positioned To Weather A Severe Recession In 2025 Stress Test; 22 Of Largest Banks Saw An Aggregate Decline Of 1.8% Of Common Equity Tier 1 Capital Under Hypothetical Recession, Total Losses Of More Than $550B; Banks That Were Tested Maintained Capital Ratios Of More Than Double Minimum Requirements Under Fed Stress Test; Fed Says If It Finalizes Proposal To Average Test Results Over 2-Years, Banks Would Have Aggregate Capital Decline Of 2.3% In 2024 And 2025 Combined'

Offerings

NVVE

Nuvve Holding  Files For Mixed Shelf Of Up To $300M

<a href="https://www.youtube.com/watch?v=nWcpp2YU6xk" title="https://www.youtube.com/watch?v=nWcpp2YU6xk">https://www.youtube.com/watch?v=nWcpp2YU6xk</a>

Macro Notification

Politics

General

President Trump Says Europe Has Been Very Tough On Trade; Have Good Relationship But Is Tough Situation; On Europe Trade Says We Have The Cards; Problem Is Europe Has A Lot Of Taxes And They Sue Our Companies

<a href="https://www.youtube.com/watch?v=nWcpp2YU6xk">https://www.youtube.com/watch?v=nWcpp2YU6xk</a>

President Trump Says I Would Love Powell To Resign As Federal Reserve Chair; Powell Making A Big Mistake; I Won't Put Someone In That Wants To Keep Rates Where They Are; We Should Be Paying 1%

Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
Provides Current Update to 2025 Earnings Performance
Related Conference Call to Be Held On July 30, 2025
﻿
CINCINNATI, June 27, 2025--Chemed Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange.
﻿
Chemed also announced developments related to second quarter earnings and full year 2025 guidance.
﻿
In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarterly earnings update, VITAS internal projections showed that the Florida consolidated program would end the 2025 government fiscal year ending on September 30, 2025 (2025 Cap Year) with a Medicare Cap cushion. Actual Medicare admissions in both April and May 2025 in Florida were weaker than anticipated and lower than VITAS' internal projections. As a result, VITAS now projects a Medicare Cap revenue limitation for the 2025 Cap Year of $18 million to $25 million related to the Florida consolidated program, excluding Tallahassee. The above projection includes actual results through May. Actual June results, which show better admissions than projected through the first half of the month, and actual results in the third quarter could have a significant impact on this projection. Previous guidance for 2025 earnings did not include any Florida Medicare Cap.
﻿
The source of the Medicare Cap in the Florida consolidated program relates to two factors. The first factor is the "community access" program. While community access has provided for a higher-than-average ADC growth rate and revenue growth rate at VITAS over the past two years, it adds pressure to the Medicare Cap due to patients accessing hospice care earlier in their disease trajectory.
﻿
The second factor is the rate differential between the nationally determined increase in the Medicare Cap per admission and the actual reimbursement increase in our Florida consolidated programs, excluding Tallahassee, for the 2025 Cap Year. Specifically, the Medicare Cap per admission amount increased 2.9% while the Florida consolidated program reimbursement increase was 5.2%. VITAS estimates this rate differential will negatively impact the Florida consolidated program's Medicare Cap calculation by approximately $25 million for the 2025 government fiscal year, accounting for most, if not all, of the total revenue limitation discussed above.
﻿
&nbsp;
&nbsp;
On June 20, 2025, the State of Florida announced that VITAS has received a Certificate of Need (CON) to begin operating in Pinellas County, Florida. Pinellas is the most densely populated county in Florida and has a hospice utilization rate below the state average. There were approximately 8,600 Medicare admissions to existing hospice providers in Pinellas County in 2024. Entering Pinellas County represents a significant opportunity for VITAS in 2026 and beyond for both overall growth and Medicare Cap mitigation.
﻿
Based on the new start locations in Florida, primarily Marion County and Pinellas County, combined with operational changes currently being made in the Florida programs, management expects not to have any significant level of Medicare Cap revenue limitation in our Florida consolidated program for the 2026 fiscal year. This expectation assumes that the rate differential discussed above does not recur for the 2026 Cap Year.&nbsp;&nbsp;In the event that the rate differential does recur, VITAS will respond with further mitigation strategies at the outset of the 2026 Cap Year.
﻿
While less financially significant than the VITAS Medicare Cap situation, during the second quarter of 2025, Roto-Rooter began to experience unexpected weakness in its residential business' demand compared to internal projections. This weakness represents a break from the trends experienced in the first quarter of 2025. Preliminary results for commercial demand in the second quarter of 2025 continue to reflect improved trends but not enough to offset the lower residential demand.
﻿
Management is in the process of analyzing second quarter performance and the impact of these developments on second quarter results and on full-year 2025 guidance. A full discussion of the analysis will be included with our second quarter 2025 release and related investor conference call.
﻿
Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, July 30, 2025, to discuss the company's quarterly results and to provide an update on its business.
Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home &#x7C; Chemed Corporation or the hosting website <a href="https://edge.media-server.com/mmc/p/vzh53v7p" title="https://edge.media-server.com/mmc/p/vzh53v7p">https://edge.media-server.com/mmc/p/vzh53v7p</a>.
Participants may also register via teleconference at: https://register-conf.media-server.com/register/BI1cf6ed1d293547f9af3111729ba98b48.
Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
﻿
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed's website.
﻿
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (<a href="http://www.chemed.com/">www.chemed.com</a>) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services.

Guidance

Chemed Projects $18M–$25M Medicare Cap Revenue Limitation For VITAS Florida Program In 2025 Due To Weaker Admissions And Rate Disparity; Says Management Is In The Process Of Analyzing Q2 Performance And The Impact Of These Developments On Q2 Results And On FY25 Guidance; Expects No Significant Medicare Cap Impact In 2026

Ecopetrol S.A. Announces It Has Extended The Agreement To Reduce By 50% The Conversion Fees For The Issuance And Cancellation Of ADRs In The United States

Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) has outperformed the market over the past 15 years by 10.67% on an annualized basis producing an average annual return of 23.33%. Currently, Taiwan Semiconductor has a market capitalization of $1.19 trillion. 
Buying $1000 In TSM: If an investor had bought $1000 of TSM stock 15 years ago, it would be worth $23,111.22 today based on a price of $228.57 for TSM at the time of writing.
<h3>Taiwan Semiconductor's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751057111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Taiwan Semiconductor 15 Years Ago Would Be Worth Today

MSGS

Madison Square Garden Sports Says Media Rights Deal Between Units Of MSG Networks Amended Effective January 1, 2025; New York Knicks Annual Rights Fee Reduced By 28%; New York Rangers Annual Rights Fee Reduced By 18%

President Trump Says Canada Difficult To Deal With; On Canada Says We Have All Cards; We Have Such Power Over Canada

<a href="https://www.bloomberg.com/news/articles/2025-06-27/trump-officials-met-with-walmart-on-direct-to-patient-drug-sales">https://www.bloomberg.com/news/articles/2025-06-27/trump-officials-met-with-walmart-on-direct-to-patient-drug-sales</a>

'Trump Officials Met with Walmart on Direct-to-Patient Drug Sales'- Bloomberg

Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#CSE">QNTM</a>) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares ("MVS") at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the "Offering"). The Company expects that the entirety of the Offering will be subscribed for by the existing holders of MVS.

CSE:QNTM

QNTM

Quantum Biopharma Announces Private Placement

WIIM

Venus Concept shares are trading higher after Madryn Asset Management increased its stake in the company to 85.5%.

Comments

SPDR Portfolio Intermediate Term Corporate Bond ETF

Notizie

Ultime notizie per SPDR Portfolio Intermediate Term Corporate Bond ETF (ARCA:SPIB)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO